Clinical Trials Directory

Trials / Completed

CompletedNCT03005353

Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.

Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

Fungal infections have increased over the last two decades, largely because of the increasing size of the population at risk, including patients who are immunocompromised, broad-spectrum antibiotics and intravascular catheter users. Essential oils and other extracts of plants have evoked interest as sources of natural products. They have been shown to possess antibacterial, antifungal, antiviral, insecticidal and antioxidant properties. To the best of our knowledge, no study has examined the efficacy of cumin seed extract on relieving vulvovaginal candidiasis in vivo.

Conditions

Interventions

TypeNameDescription
DRUGCumin seed extractpatients will receive the drug in suppository form
DRUGclotrimazolepatients will receive the drug in suppository form

Timeline

Start date
2018-03-01
Primary completion
2019-10-31
Completion
2020-01-31
First posted
2016-12-29
Last updated
2020-06-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03005353. Inclusion in this directory is not an endorsement.